"In light of the controversy around the bill and its potential to impact all of us and future generations, we urge you, as the minister in charge, to withdraw the BRAI bill and work with other relevant ministries to bring in a bio-safety law," NGO Greenpeace said in a letter to Science and Technology Minister Jaipal Reddy.
The BRAI bill, which seeks to establish a statutory independent regulator for biotech sector covering research, transport, import, manufacture and use of organisms and products of modern biotechnology, was introduced in the Lok Sabha on Monday.
In its letter, Greenpeace alleged the bill was drafted in a "secretive fashion with no opportunity for the general public to comment" on a legislation that deals with something as important as food safety.
"It is unfortunate that this is happening despite the strong recommendation from a Parliamentary standing committee on Agriculture against such a regulation with a limited mandate," it said.
Introducing the bill, Reddy had said it was being done within the legislative competence of Parliament.
As per the bill, the biotech regulator would regulate trials preceding the clinical trials in the health sector and the present mechanism for regulating clinical trials would continue.
You’ve reached your limit of {{free_limit}} free articles this month.
Subscribe now for unlimited access.
Already subscribed? Log in
Subscribe to read the full story →
Smart Quarterly
₹900
3 Months
₹300/Month
Smart Essential
₹2,700
1 Year
₹225/Month
Super Saver
₹3,900
2 Years
₹162/Month
Renews automatically, cancel anytime
Here’s what’s included in our digital subscription plans
Exclusive premium stories online
Over 30 premium stories daily, handpicked by our editors


Complimentary Access to The New York Times
News, Games, Cooking, Audio, Wirecutter & The Athletic
Business Standard Epaper
Digital replica of our daily newspaper — with options to read, save, and share


Curated Newsletters
Insights on markets, finance, politics, tech, and more delivered to your inbox
Market Analysis & Investment Insights
In-depth market analysis & insights with access to The Smart Investor


Archives
Repository of articles and publications dating back to 1997
Ad-free Reading
Uninterrupted reading experience with no advertisements


Seamless Access Across All Devices
Access Business Standard across devices — mobile, tablet, or PC, via web or app
